Amplia Therapeutics Limited
INNMF
$0.12
-$0.005-4.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.73% | -29.87% | -1.68% | 16.43% | -0.91% |
| Total Depreciation and Amortization | -3.62% | -4.83% | 1.40% | 0.70% | 0.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.73% | -189.08% | 1.67% | -37.01% | 0.92% |
| Change in Net Operating Assets | 3.74% | -- | -- | -- | -0.89% |
| Cash from Operations | 3.73% | -374.05% | -1.66% | 25.85% | -0.91% |
| Capital Expenditure | 0.00% | -400.00% | 0.00% | 85.71% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00% | -400.00% | 0.00% | 85.71% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | 0.00% |
| Total Debt Repaid | 0.00% | 97.23% | 0.00% | 29.53% | 0.00% |
| Issuance of Common Stock | 0.00% | 204.88% | 0.00% | 2,134,000.00% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -157.22% | 0.00% | -2,643.06% | 0.00% |
| Cash from Financing | -3.73% | 391.62% | 1.68% | 444.78% | -0.89% |
| Foreign Exchange rate Adjustments | -3.77% | 431.25% | -1.59% | -800.00% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.73% | 422.70% | 1.68% | 151.75% | -0.91% |